{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:07:52Z","timestamp":1784740072547,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:00:00Z","timestamp":1503619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01AI094409"],"award-info":[{"award-number":["R01AI094409"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL134510"],"award-info":[{"award-number":["R01HL134510"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Texas Hepatocellular Carcinoma Consortium","award":["RP150587"],"award-info":[{"award-number":["RP150587"]}]},{"name":"NIH","award":["T32DK060445"],"award-info":[{"award-number":["T32DK060445"]}]},{"name":"NIH","award":["5T32HL092332"],"award-info":[{"award-number":["5T32HL092332"]}]},{"name":"NIH","award":["P30CA125123"],"award-info":[{"award-number":["P30CA125123"]}]},{"name":"NIH","award":["P30DK56338"],"award-info":[{"award-number":["P30DK56338"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.omtm.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T20:38:00Z","timestamp":1504211880000},"page":"32-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["In Situ Liver Expression of HBsAg\/CD3-Bispecific Antibodies for HBV Immunotherapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Robert L.","family":"Kruse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Shum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Legras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Barzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Pankowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Dimiter","family":"Bissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2017.08.006_bib1","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtm.2017.08.006_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/j.gastro.2010.04.048","article-title":"Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study","volume":"139","author":"Liu","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtm.2017.08.006_bib3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.23327","article-title":"Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B","volume":"51","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2017.08.006_bib4","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy","volume":"126","author":"Werle-Lapostolle","year":"2004","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.omtm.2017.08.006_bib5","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/hep.22956","article-title":"Benefits and risks of interferon therapy for hepatitis B","volume":"49","author":"Perrillo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2017.08.006_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T\u00a0cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2017.08.006_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 produced by T\u00a0cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtm.2017.08.006_bib8","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2017.08.006_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B virus--specific and global T-cell dysfunction in chronic hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtm.2017.08.006_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.gastro.2007.11.002","article-title":"T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes","volume":"134","author":"Bohne","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtm.2017.08.006_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2013.04.047","article-title":"T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice","volume":"145","author":"Krebs","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtm.2017.08.006_bib12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/314628a0","article-title":"Hybrid antibodies can target sites for attack by T\u00a0cells","volume":"314","author":"Staerz","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2017.08.006_bib13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1073\/pnas.83.5.1453","article-title":"Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity","volume":"83","author":"Staerz","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.08.006_bib14","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1158\/1078-0432.CCR-15-0612","article-title":"FDA approval: blinatumomab","volume":"21","author":"Przepiorka","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtm.2017.08.006_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00280-015-2728-5","article-title":"A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T\u00a0cell coreceptor CD3","volume":"75","author":"Mau-S\u00f8rensen","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.omtm.2017.08.006_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/antib2030415","article-title":"In\u00a0vivo secretion of bispecific antibodies recruiting lymphocytic effector cells","volume":"2","author":"Compte","year":"2013","journal-title":"Antibodies"},{"key":"10.1016\/j.omtm.2017.08.006_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1089\/hum.2016.122","article-title":"Treatment of human B-cell lymphomas using minicircle DNA vector expressing anti-CD3\/CD20 in a mouse model","volume":"28","author":"Pang","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2017.08.006_bib18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.4356","article-title":"Elimination of large tumors in mice by mRNA-encoded bispecific antibodies","volume":"23","author":"Stadler","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2017.08.006_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/jhep.2002.31867","article-title":"Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties","volume":"35","author":"Galun","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2017.08.006_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-0676.2001.021003207.x","article-title":"Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patients","volume":"21","author":"van Nunen","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.omtm.2017.08.006_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2567.1998.00426.x","article-title":"Human monoclonal antibodies specific to hepatitis B virus generated in a human\/mouse radiation chimera: the Trimera system","volume":"93","author":"Eren","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.omtm.2017.08.006_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jhep.2000.9632","article-title":"Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-Trimera mouse model and in HBV chronic carrier chimpanzees","volume":"32","author":"Eren","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2017.08.006_bib23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","article-title":"Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA","volume":"6","author":"Liu","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.08.006_bib24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.gt.3302210","article-title":"Hydroporation as the mechanism of hydrodynamic delivery","volume":"11","author":"Zhang","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.08.006_bib25","doi-asserted-by":"crossref","first-page":"e60005","DOI":"10.1371\/journal.pone.0060005","article-title":"A mouse model for studying the clearance of hepatitis B virus in\u00a0vivo using a luciferase reporter","volume":"8","author":"Liang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2017.08.006_bib26","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/hep.23575","article-title":"Bioluminescence imaging allows measuring CD8 T\u00a0cell function in the liver","volume":"51","author":"Stabenow","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2017.08.006_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/biom2010023","article-title":"A new method to determine antigen-specific CD8+ T\u00a0cell activity in\u00a0vivo by hydrodynamic injection","volume":"2","author":"Rai","year":"2012","journal-title":"Biomolecules"},{"key":"10.1016\/j.omtm.2017.08.006_bib28","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.202398599","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume":"99","author":"Yang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.08.006_bib29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/hum.2012.041","article-title":"Recognition of glioma stem cells by genetically modified T\u00a0cells targeting EGFRvIII and development of adoptive cell therapy for glioma","volume":"23","author":"Morgan","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2017.08.006_bib30","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1073\/pnas.84.5.1374","article-title":"Identification of a monoclonal antibody specific for a murine T3 polypeptide","volume":"84","author":"Leo","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.08.006_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0161-5890(95)00087-9","article-title":"A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL","volume":"33","author":"Jost","year":"1996","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omtm.2017.08.006_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/mt.2014.156","article-title":"Engager T\u00a0cells: a new class of antigen-specific T\u00a0cells that redirect bystander T\u00a0cells","volume":"23","author":"Iwahori","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.08.006_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/2326-6066.CIR-14-0127","article-title":"The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in\u00a0vivo antitumor activity","volume":"3","author":"Hudecek","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omtm.2017.08.006_bib34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s11095-010-0338-9","article-title":"Hydrodynamic gene delivery and its applications in pharmaceutical research","volume":"28","author":"Bonamassa","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.omtm.2017.08.006_bib35","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1128\/JVI.01024-14","article-title":"Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice","volume":"88","author":"Qi","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2017.08.006_bib36","doi-asserted-by":"crossref","first-page":"25552","DOI":"10.1038\/srep25552","article-title":"The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2017.08.006_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0008-8749(86)90278-9","article-title":"Fc receptors on monocytes cause OKT3-treated lymphocytes to internalize T3 and to secrete IL-2","volume":"98","author":"Rinnooy Kan","year":"1986","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.omtm.2017.08.006_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/protein\/gzs040","article-title":"Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells","volume":"25","author":"Kuo","year":"2012","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.omtm.2017.08.006_bib39","doi-asserted-by":"crossref","first-page":"e28810","DOI":"10.4161\/onci.28810","article-title":"Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications","volume":"3","author":"Compte","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omtm.2017.08.006_bib40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.23778","article-title":"Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells","volume":"52","author":"Neumann","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2017.08.006_bib41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.gt.3302449","article-title":"Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice","volume":"12","author":"Dumortier","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.08.006_bib42","doi-asserted-by":"crossref","first-page":"13412","DOI":"10.1128\/JVI.79.21.13412-13420.2005","article-title":"Liver-directed gamma interferon gene delivery in chronic hepatitis C","volume":"79","author":"Shin","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2017.08.006_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virol.2004.06.017","article-title":"Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus","volume":"327","author":"Zhu","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.omtm.2017.08.006_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/15258160151134944","article-title":"Use of anti-CD3 x anti-HER2\/neu bispecific antibody for redirecting cytotoxicity of activated T\u00a0cells toward HER2\/neu+ tumors","volume":"10","author":"Sen","year":"2001","journal-title":"J.\u00a0Hematother. Stem Cell Res."},{"key":"10.1016\/j.omtm.2017.08.006_bib45","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/hep.25875","article-title":"Targeted delivery of interferon-\u03b1 to hepatitis B virus-infected cells using T-cell receptor-like antibodies","volume":"56","author":"Ji","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2017.08.006_bib46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2015.02.048","article-title":"Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I","volume":"63","author":"Berraondo","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtm.2017.08.006_bib47","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0161-5890(01)00027-X","article-title":"Generation and characterization of a novel tetravalent bispecific antibody that binds to hepatitis B virus surface antigens","volume":"37","author":"Park","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omtm.2017.08.006_bib48","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4161\/mabs.26390","article-title":"A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity","volume":"5","author":"Tan","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.omtm.2017.08.006_bib49","first-page":"637","article-title":"Preparation and application of anti-HBx\/anti-CD3 bispecific monoclonal antibody (BsAb) retargeting effector cells for lysis of human hepatoma xenografts in nude mice","volume":"3","author":"Liao","year":"1996","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omtm.2017.08.006_bib50","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/jgm.921","article-title":"Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules","volume":"8","author":"Sebesty\u00e9n","year":"2006","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2017.08.006_bib51","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2017.08.006_bib52","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/mt.2015.103","article-title":"Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals","volume":"23","author":"Thess","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.08.006_bib53","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/gt.2016.46","article-title":"Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system","volume":"23","author":"DeRosa","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.08.006_bib54","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B\u00a0virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2017.08.006_bib55","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/j.gastro.2012.03.006","article-title":"Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice","volume":"142","author":"Huang","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtm.2017.08.006_bib56","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2015.11.032","article-title":"In\u00a0vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides","volume":"64","author":"Billioud","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtm.2017.08.006_bib57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.25732","article-title":"Hepatitis B surface antigen quantification: not what it seems on the surface","volume":"56","author":"Locarnini","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2017.08.006_bib58","first-page":"51481","article-title":"Transient expression of proteins by hydrodynamic gene delivery in mice","volume":"87","author":"Kovacsics","year":"2014","journal-title":"J.\u00a0Vis. Exp."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050117300955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050117300955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T06:58:01Z","timestamp":1535439481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050117300955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":58,"alternative-id":["S2329050117300955"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2017.08.006","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Situ Liver Expression of HBsAg\/CD3-Bispecific Antibodies for HBV Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors.","name":"copyright","label":"Copyright"}]}}